Liver dysfunction in celiac disease.

Area of Science:

• Gastroenterology
• Hepatology
• Immunology

Background:

• Celiac disease (gluten-sensitive enteropathy) is associated with a broad range of liver abnormalities.
• Two primary forms of liver damage, cryptogenic and autoimmune, are strongly linked to celiac disease.

Purpose of the Study:

• To investigate the relationship between celiac disease and liver damage.
• To differentiate the outcomes of cryptogenic and autoimmune liver injuries in celiac patients following dietary interventions.

Main Methods:

• Review of clinical presentations and histological findings in celiac patients with liver abnormalities.
• Analysis of the association between celiac disease and specific autoimmune liver disorders.
• Evaluation of the impact of a gluten-free diet on liver function in these patients.

Main Results:

• Approximately 50% of untreated celiac patients exhibit cryptogenic hypertransaminasemia, often presenting as non-specific reactive hepatitis (celiac hepatitis) that resolves with a gluten-free diet.
• More severe liver injury, including chronic hepatitis and cirrhosis, can occur but may improve with dietary changes.
• A significant prevalence of celiac disease is observed in patients with primary biliary cirrhosis (3-7%), autoimmune hepatitis (3-6%), and primary sclerosing cholangitis (2-3%).
• Autoimmune liver dysfunction in celiac disease typically does not improve with a gluten-free diet.

Conclusions:

• Celiac disease is associated with both cryptogenic (celiac hepatitis) and autoimmune liver diseases.
• The response to a gluten-free diet differs between these two forms of liver injury.
• Further research is needed to determine if these liver injuries are distinct entities or part of a spectrum influenced by genetic factors and gluten exposure duration.